Drug Database
Back to search

Netherlands· NL-0d8b89466bf5

Dapagliflozine Viatris 10 mg, filmomhulde tabletten

A dapagliflozin product containing dapagliflozine, registered in Netherlands by Viatris Limited. The same ATC class is registered in 16 of our 19 countries.

ATC A10BK01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDapagliflozine Viatris 10 mg, filmomh…ATCA10BK01REGISTER NO.NL-0d8b89466bf5PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dapagliflozineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dapagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK01 (dapagliflozin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search dapagliflozin products by name

Dapagliflozin · ATC A10BK01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dapagliflozin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.33 in United States to $4.38 in Switzerland — a ×13 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Dapagliflozin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.38
  • IT Italy$3.42
  • US United States$0.33 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DAPAGLIFLOZINE
Manufacturer
Viatris Limited
Country
Netherlands (NL)
ATC code
A10BK01
ATC class
Dapagliflozin
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/23/1721

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

426 interactions on record for dapagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dapagliflozin against other medicinesHow interaction checks work

Dapagliflozin · interactions on record

426 records

  • 1 severe
  • 378 moderate
  • 47 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • PapaverineA03AD01moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dapagliflozin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Dapagliflozin +pharma, Dapagliflozin Devatis
  • Belgium · Dapagliflozin Ab, Dapagliflozin Eg
  • Bulgaria · Dapagliflozin Sandoz, Dapagliflozin Tchaikapharma
  • Cyprus · Daforbis, Dapagliflozin Farmoz
  • Czechia · Dagetia, Dagrafors
  • Germany · Daglin, Dapagliflozin 123-Acurae Pharma
  • Denmark · Dapagliflozin, Dapagliflozin "sandoz"
  • Estonia · Dagrafors, Dapagliflozin Alembic
  • Spain · Daforbis, Dapagliflozina Aurovitas
  • Finland · Dapagliflozin Devatis, Dapagliflozin Krka
  • France · Dapagliflozine Arrow, Dapagliflozine Biogaran
  • United Kingdom (Northern Ireland) · Daforbis, Dapagliflozin
  • Greece · Brolertix, Daforbis
  • Croatia · Daforbis, Dagrafors
  • Hungary · Dagrafors, Dapagliflozin Sandoz
  • Ireland · Dapagliflozin Clonmel, Dapagliflozin Krka
  • Iceland · Dapagliflozin Krka, Dapagliflozin Krka D.D.
  • Italy · Dapagliflozin Aurobindo, Dapagliflozin Doc
  • Liechtenstein · Dapagliflozin Viatris, Edistride
  • Lithuania · Dagrafors, Dapagliflozin Accord
  • Luxembourg · Dapagliflozin Eg
  • Latvia · Daglin, Dagrafors
  • Malta · Dapagliflozin Ascend, Dapagliflozin Aurobindo
  • Norway · Dapagliflozin Alembic, Dapagliflozin Devatis
  • Poland · Daforbis, Dagrafors
  • Portugal · Dalzior, Dapagliflozin Ipca
  • Romania · Daforbis, Dagetia
  • Sweden · Daforbis, Dapagliflozin Adalvo
  • Slovenia · Dagrafors, Dapagliflozin Hcs
  • Slovakia · Dagetia, Dagrafors

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fcd9eb69-aa14-4c90-8369-53fd22a7e0e6
GET /v1/drugs/fcd9eb69-aa14-4c90-8369-53fd22a7e0e6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/dapagliflozin-viatris-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Dapagliflozin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129667",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMLAURILSULFAAT",
    "POLYVINYLALCOHOL (E 1203)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "DAPAGLIFLOZINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2023/03/24",
  "procedure_number": "EMEA/H/C/006006",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/23/1721",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console